Drug intelligence / Profile preview

Fu Zheng Kang Ai Granule

Development stage: Preclinical
Administration: Oral

Overview

Fu Zheng Kang Ai Granule is a Traditional Chinese Medicine (TCM) formula primarily used as an adjuvant therapy for HIV/AIDS. It is composed of multiple herbs, including Astragalus, Codonopsis, Turmeric, and Licorice. The drug aims to enhance the immune system, specifically by increasing CD4+ and CD8+ T lymphocyte counts in patients with HIV infection. Studies have indicated its potential to improve immune function in HIV/AIDS patients.

Other names: 扶正抗艾颗粒Fu Zheng Anti-AIDS Formula

Targets

CD8A (CD8 alpha/beta Coreceptor)CD4 (T lymphocyte surface antigen)

Beyond the preview

Go deeper on Fu Zheng Kang Ai Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fu Zheng Kang Ai Granule.

Explore the full profile